IgA Nephropathy Clinical Trial Pipeline: Emerging Therapies and Key Developments Shaping the Treatment Landscape | DelveInsight

IgA Nephropathy Clinical Trial Pipeline: Emerging Therapies and Key Developments Shaping the Treatment Landscape | DelveInsight

The IgA Nephropathy clinical trial analysis report delivers important insights into ongoing research of 25+ pipeline IgA Nephropathy drugs, clinical strategies, upcoming therapeutics, and commercial analysis. (Albany, US) On October

Read More

Influenza Clinical Trial Drug Development Pipeline Expands with Contributions from 120+ Key Companies | DelveInsight

The Influenza clinical trial analysis report delivers important insights into ongoing research on 120+ pipeline Influenza Drugs, clinical strategies, upcoming therapeutics, and commercial analysis. (Albany, US) On October 08, 2026,

Read More

the Nontuberculous Mycobacteria Infections Treatment Market Size in the 7MM was more than USD 750 million in 2025 and It is projected to grow at a CAGR of 12.6% by 2036

The Nontuberculous Mycobacterial market report delivers important insights into ongoing research on Nontuberculous Mycobacterial Drugs, clinical strategies, upcoming therapeutics, and commercial analysis. (Albany, US) On October 08, 2026, DelveInsight’s “Nontuberculous

Read More

Performance Roofing & Siding Celebrates Pontiac’s First Hauntiac Parade

Performance Roofing & Siding celebrated Pontiac’s inaugural Hauntiac Parade on October 3 with a festive ghost-and-goblin display. Performance Roofing & Siding helped celebrate Pontiac’s inaugural Hauntiac Parade on October 3

Read More

Thyroid Eye Disease Market Set to Witness Growth with Rising Awareness, Early Diagnosis, and Emerging Targeted Therapies by 2034 – DelveInsight | Immunovant Sciences, Viridian Therapeutics, Novartis

The Key Thyroid Eye Disease Companies in the market include – Horizon Therapeutics, Immunovant Sciences, Viridian Therapeutics, Novartis Pharmaceuticals, Sling Therapeutics, Regeneron Pharmaceuticals, ValenzaBio, and others. (Albany, US), October 08,

Read More

Anesthesia Machines Market to Reach USD 34.40 Billion by 2034, Driven by Rising Surgical Volumes, Ambulatory Surgical Center Expansion, and AI-Enabled Anesthesia Platforms

Key Anesthesia Machines companies such as Shenzhen Comen Medical Instruments Co., Ltd., SternMed GmbH, General Electric Company, Koninklijke Philips N.V., Drägerwerk AG & Co. KgaA, Mindray DS USA, Inc., Heal

Read More

Congenital Hyperinsulinism Market to Grow at 12% CAGR Through 2036, Driven by Advancements in Targeted Therapies and Increasing Diagnosis | DelveInsight

The market dynamics for Congenital Hyperinsulinism (CHI) are witnessing significant growth, driven by increasing disease awareness, advancements in genetic testing, improvements in neonatal diagnosis, and growing demand for effective treatments

Read More

Hereditary Transthyretin Amyloidosis Market is Projected to Reach USD 3 Billion by 2025 and Grow at 11% CAGR Through 2036 Owing to Advancements in RNA-based and Gene-Editing Therapies | DelveInsight

The market dynamics for Hereditary Transthyretin Amyloidosis (hATTR) are witnessing robust growth driven by increasing disease awareness, improvements in genetic testing and diagnosis, advancements in RNA-based gene-silencing therapies, and growing

Read More

Multiple Sclerosis Clinical Trial Pipeline Appears Robust With 75+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight

The Multiple Sclerosis clinical trial analysis report delivers important insights into ongoing research on 75+ pipeline Multiple Sclerosis Drugs, clinical strategies, upcoming therapeutics, and commercial analysis. (Albany, US) On October

Read More

Myelodysplastic Syndrome Clinical Trial Pipeline: DelveInsight Highlights Major Advances, Transformative Therapies, and 120+ Leading Players Wheeling the Therapeutics Landscape

The Myelodysplastic Syndrome clinical trial analysis report delivers important insights into ongoing research on 120+ pipeline Myelodysplastic Syndrome Drugs, clinical strategies, upcoming therapeutics, and commercial analysis. (Albany, US) On October

Read More